What is InBrace?
InBrace is a pioneering medical technology company that has redefined the orthodontic experience through its patented smart wire system. Unlike traditional appliances that require frequent manual adjustments, the InBrace solution utilizes advanced materials science to provide continuous, gentle force, effectively automating the tooth-straightening process. Positioned at the intersection of digital health and orthodontics, the company serves a growing demographic of patients seeking aesthetic, high-performance treatment options. Its market position is bolstered by a strong intellectual property portfolio and a strategic focus on clinical efficacy, making it a standout entity in the broader medtech sector.
How much funding has InBrace raised?
InBrace has raised a total of $218.6M across 6 funding rounds:
Series A
$5.6M
Series B
$20M
Series C
$45M
Debt
$1M
Series D
$102M
Debt
$45M
Series A (2017): $5.6M, investors not publicly disclosed
Series B (2018): $20M, investors not publicly disclosed
Series C (2019): $45M supported by Vivo Capital, venBio Partners, and Novo Holdings
Debt (2020): $1M featuring PPP
Series D (2021): $102M backed by BlackRock, RTW Investments, Farallon Capital Management, Endeavour Vision, Soleus Capital, Marshall Wace, and MVM Partners
Debt (2022): $45M with participation from Horizon Technology Finance
Key Investors in InBrace
Vivo Capital
A global healthcare investment firm founded in 1996, specializing in private and public equity as well as venture capital within the life sciences sector.
venBio Partners
A life sciences investment firm that partners with industry leaders to develop innovative medicines and technologies, focusing on novel therapeutics for unmet medical needs.
BlackRock
A global investment management firm providing comprehensive financial services, including alternative investments and risk management for institutional and individual clients.
What's next for InBrace?
Looking ahead, the recent $45M provides InBrace with the necessary liquidity to accelerate its commercialization efforts and deepen its market penetration. As the company transitions into a more mature phase of its lifecycle, the focus will likely shift toward scaling manufacturing capabilities, expanding its provider network, and potentially exploring new applications for its smart wire technology. The backing of high-profile institutional investors suggests a long-term strategy aimed at sustained innovation and potential market leadership in the global orthodontic space. By maintaining its focus on transformative healthcare solutions, InBrace is well-positioned to capitalize on the increasing demand for patient-centric, technology-driven dental care.
See full InBrace company page
